2Suppliers
0Customers
3Debt Items
20Related Chains

Altimmune, Inc. Suppliers

TickerNameConfidenceEvidence
MEDERIS-DIABETES-LLC MEDERIS-DIABETES-LLC 92% Pursuant to a license agreement between the Company and Mederis Diabetes, LLC ("Mederis") (the "Mederis IP License Agreement"), we are the exclusive licensee of patent rights owned by Mederis to deve…
TITAN-PARTNERS-GROUP-LLC TITAN-PARTNERS-GROUP-LLC 92% The Company also entered into a Placement Agency Agreement with Titan Partners Group LLC, a division of American Capital Partners, LLC

Altimmune, Inc. Customers

No clients on recordNo downstream customers found in our database for Altimmune, Inc..

Altimmune, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
ALT-DEBT Debt stack $35.8M 90% Market cache reports total debt of $35.8M.
ALT-DEBT-7697 Xbrl Convertible 90% xbrl convertible detail from xbrl 2017-12-31.
ALT-DEBT-7696 Warrants outstanding: 1593753 90% xbrl warrant detail from xbrl 2024-12-31.

Altimmune, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Altimmune, Inc..

Altimmune, Inc. Ownership

HolderNameConfidenceEvidence
ALT-OWNER-BLACKROCK-INC BlackRock, Inc. 90% 13F overlay lists BlackRock, Inc. as top holder; 176 tracked holders.

Altimmune, Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
BCYC Bicycle Therapeutics plc 100.00 2
DYN Dyne Therapeutics, Inc. 100.00 2
CMPS COMPASS Pathways plc 100.00 2
ENGN enGene Therapeutics Inc. 100.00 2
KURA Kura Oncology, Inc. 100.00 2
MDGL Madrigal Pharmaceuticals, Inc. 100.00 2
PHGE BiomX Inc. 100.00 2
SGHT Sight Sciences, Inc. 100.00 2
RCUS Arcus Biosciences, Inc. 100.00 2
REPL Replimune Group, Inc. 100.00 2
MAZE Maze Therapeutics, Inc. 100.00 2
OBIO Orchestra BioMed Holdings, Inc. 100.00 2
VRDN Viridian Therapeutics, Inc. 100.00 2
IRON Disc Medicine, Inc. 100.00 2
SVRA Savara Inc. 100.00 2
ALEC Alector, Inc. 100.00 2
TGTX TG Therapeutics, Inc. 50.00 2
HRTX Heron Therapeutics, Inc. 50.00 2
PHAT Phathom Pharmaceuticals, Inc. 50.00 2
MLTX MoonLake Immunotherapeutics 50.00 2